当前位置: X-MOL 学术Mucosal Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
IL-1β as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses.
Mucosal Immunology ( IF 8 ) Pub Date : 2018-07-01 , DOI: 10.1038/s41385-018-0017-4
D Lapuente 1, 2 , M Storcksdieck Genannt Bonsmann 1 , A Maaske 1 , V Stab 1 , V Heinecke 1 , K Watzstedt 1 , R Heß 1 , A M Westendorf 3 , W Bayer 4 , C Ehrhardt 5 , M Tenbusch 1, 2
Affiliation  

A universal influenza vaccine must provide protection against antigenically divergent influenza viruses either through broadly neutralizing antibodies or cross-reactive T cells. Here, intranasal immunizations with recombinant adenoviral vectors (rAd) encoding hemagglutinin (HA) and nucleoprotein (NP) in combination with rAd-Interleukin-(IL)-1β or rAd-IL-18 were evaluated for their efficacy in BALB/c mice. Mucosal delivery of rAd-IL-1β enhanced HA-specific antibody responses including strain-specific neutralizing antibodies. Nevertheless, the beneficial effects on the local T cell responses were much more impressive reflected by increased numbers of CD103+CD69+ tissue-resident memory T cells (TRM). This increased immunogenicity translated into superior protection against infections with homologous and heterologous strains including H1N1, pH1N1, H3N2, and H7N7. Inhibition of the egress of circulating T cells out of the lymph nodes during the heterologous infection had no impact on the degree of protection underscoring the unique potential of TRM for the local containment of mucosal infections. The local co-expression of IL-1β and antigen lead to the activation of critical checkpoints in the formation of TRM including activation of epithelial cells, expression of chemokines and adhesion molecules, recruitment of lung-derived CD103+ DCs, and finally local TRM imprinting. Given the importance of TRM-mediated protection at mucosal barriers, this study has major implications for vaccine development.

中文翻译:

IL-1β作为粘膜疫苗佐剂:组织驻留记忆T细胞的特异性诱导提高了对甲型流感病毒的异亚型免疫。

通用流感疫苗必须通过广泛中和抗体或交叉反应性 T 细胞提供针对抗原性不同流感病毒的保护。在这里,使用编码血凝素 (HA) 和核蛋白 (NP) 的重组腺病毒载体 (rAd) 与 rAd-白介素-(IL)-1β 或 rAd-IL-18 组合进行鼻内免疫,评估了它们在 BALB/c 小鼠中的功效。rAd-IL-1β 的粘膜递送增强了 HA 特异性抗体反应,包括菌株特异性中和抗体。然而,CD103 + CD69 +组织驻留记忆 T 细胞 (TR RM ) 数量的增加反映了对局部 T 细胞反应的有益影响。). 这种增加的免疫原性转化为对同源和异源毒株(包括 H1N1、pH1N1、H3N2 和 H7N7)感染的卓越保护。在异源感染期间抑制循环 T 细胞流出淋巴结对保护程度没有影响,这强调了 T RM在局部遏制粘膜感染方面的独特潜力。IL-1β 和抗原的局部共表达导致 TRM 形成中关键检查点的激活,包括上皮细胞的激活、趋化因子和粘附分子的表达、肺源性 CD103 + DC 的募集以及最终的局部 T RM压印。鉴于 T RM的重要性-介导的粘膜屏障保护,这项研究对疫苗开发具有重要意义。
更新日期:2018-03-16
down
wechat
bug